Rebecca A. Powers, MD
Psychiatry · Campbell
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Powers’s office at (408) 370-6147 to ask if they take your plan before you enroll.
Drugs they prescribed that Part D paid
$50,331
Pharmacies billed $50,331 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 318) in 2024. At or below the middle of the specialty; the typical psychiatry & neurology clinician is at 0%.
282 generic and 36 brand-name prescriptions · $50,331 in drug cost · 33 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lamotrigine Er | 20 | $12,759 | $638 |
| Dayvigo | 16 | $5,427 | $339 |
| Lisdexamfetamine Dimesylate | 16 | $4,142 | $259 |
| Desvenlafaxine Succinate Er | 50 | $1,902 | $38 |
| Dexmethylphenidate Hcl Er | 12 | $696 | $58 |
See all 10 drugs
| Lamotrigine Er | 20 | $12,759 | $638 |
| Dayvigo | 16 | $5,427 | $339 |
| Lisdexamfetamine Dimesylate | 16 | $4,142 | $259 |
| Desvenlafaxine Succinate Er | 50 | $1,902 | $38 |
| Dexmethylphenidate Hcl Er | 12 | $696 | $58 |
| Venlafaxine Hcl Er | 15 | $348 | $23 |
| Lamotrigine | 12 | $257 | $21 |
| Bupropion Xl | 17 | $239 | $14 |
| Duloxetine | 16 | $101 | $6 |
| Fluoxetine | 12 | $65 | $5 |
Year by year
| 2024 | 318 | 23 | 0% (0) | 11% | $50,331 |
| 2023 | 284 | 25 | 0% (0) | 17% | $89,487 |
| 2022 | 197 | 20 | 0% (0) | 10% | $71,899 |
| 2021 | 185 | 18 | 0% (0) | 8% | $72,823 |
| 2020 | 274 | 19 | 0% (0) | 13% | $74,645 |
| 2019 | 211 | 13 | None | 9% | $50,440 |
| 2018 | 240 | 14 | 0% (0) | 12% | $35,647 |
| 2017 | 314 | 14 | None | 16% | $62,075 |
| 2016 | 291 | 15 | 0% (0) | None | $55,066 |
| 2015 | 266 | 11 | 0% (0) | 27% | $41,934 |
| 2014 | 94 | None | 0% (0) | 30% | $21,904 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Lamotrigine Er | 17 | $13,751 | $809 |
| Concerta | 17 | $7,925 | $466 |
| Dayvigo | 11 | $3,719 | $338 |
| Desvenlafaxine Succinate Er | 41 | $2,643 | $64 |
| Quetiapine Fumarate Er | 14 | $1,018 | $73 |
| Venlafaxine Hcl Er | 28 | $529 | $19 |
| Bupropion Xl | 12 | $265 | $22 |
| Lamotrigine | 14 | $238 | $17 |
| Duloxetine | 14 | $105 | $8 |
2022: 7 drugs
| Lamotrigine Er | 19 | $18,011 | $948 |
| Concerta | 11 | $5,037 | $458 |
| Desvenlafaxine Succinate Er | 29 | $2,189 | $75 |
| Olanzapine | 12 | $2,150 | $179 |
| Venlafaxine Hcl Er | 16 | $343 | $21 |
| Bupropion Xl | 15 | $331 | $22 |
| Lamotrigine | 15 | $157 | $10 |
2021: 5 drugs
| Lamotrigine Er | 14 | $7,069 | $505 |
| Desvenlafaxine Succinate Er | 30 | $2,603 | $87 |
| Quetiapine Fumarate Er | 11 | $549 | $50 |
| Lamotrigine | 21 | $354 | $17 |
| Bupropion Xl | 15 | $231 | $15 |
2020: 8 drugs
| Desvenlafaxine Succinate Er | 23 | $2,129 | $93 |
| Bupropion Xl | 19 | $1,073 | $56 |
| Quetiapine | 16 | $1,055 | $66 |
| Escitalopram | 16 | $794 | $50 |
| Lamotrigine | 27 | $694 | $26 |
| Duloxetine | 11 | $423 | $38 |
| Clonazepam | 22 | $342 | $16 |
| Venlafaxine Hcl Er | 14 | $226 | $16 |
2019: 8 drugs
| Venlafaxine Hcl Er | 12 | $1,776 | $148 |
| Desvenlafaxine Succinate Er | 13 | $924 | $71 |
| Bupropion Xl | 15 | $896 | $60 |
| Escitalopram | 19 | $837 | $44 |
| Lamotrigine | 29 | $486 | $17 |
| Olanzapine | 12 | $332 | $28 |
| Clonazepam | 15 | $72 | $5 |
| Sertraline | 12 | $9 | $1 |
2018: 9 drugs
| Olanzapine Odt | 25 | $5,663 | $227 |
| Dexmethylphenidate Hcl Er | 11 | $2,136 | $194 |
| Bupropion Xl | 17 | $984 | $58 |
| Escitalopram | 28 | $861 | $31 |
| Desvenlafaxine Succinate Er | 12 | $482 | $40 |
| Lamotrigine | 22 | $395 | $18 |
| Olanzapine | 17 | $252 | $15 |
| Clonazepam | 21 | $118 | $6 |
| Sertraline | 11 | $8 | $1 |
2017: 10 drugs
| Buprenorphine-Naloxone | 14 | $4,682 | $334 |
| Olanzapine Odt | 24 | $4,229 | $176 |
| Dexmethylphenidate Hcl Er | 12 | $2,299 | $192 |
| Bupropion Xl | 11 | $731 | $66 |
| Escitalopram | 44 | $671 | $15 |
| Clonazepam | 28 | $305 | $11 |
| Ziprasidone | 12 | $287 | $24 |
| Lamotrigine | 42 | $279 | $7 |
| Olanzapine | 20 | $144 | $7 |
| Zaleplon | 11 | $61 | $6 |
2016: 11 drugs
| Seroquel Xr | 13 | $7,684 | $591 |
| Pristiq | 25 | $7,174 | $287 |
| Dexmethylphenidate Hcl Er | 12 | $1,998 | $167 |
| Escitalopram | 49 | $1,908 | $39 |
| Olanzapine Odt | 11 | $1,561 | $142 |
| Lamotrigine Er | 12 | $1,193 | $99 |
| Bupropion Xl | 17 | $834 | $49 |
| Clonazepam | 18 | $395 | $22 |
| Olanzapine | 15 | $300 | $20 |
| Lorazepam | 13 | $191 | $15 |
| Lamotrigine | 36 | $183 | $5 |
2015: 10 drugs
| Seroquel Xr | 21 | $9,941 | $473 |
| Nuvigil | 11 | $6,216 | $565 |
| Pristiq Er | 22 | $5,508 | $250 |
| Dextroamphetamine-Amphet Er | 18 | $2,693 | $150 |
| Dexmethylphenidate Hcl Er | 11 | $1,836 | $167 |
| Bupropion Xl | 14 | $989 | $71 |
| Escitalopram | 33 | $460 | $14 |
| Clonazepam | 18 | $417 | $23 |
| Olanzapine | 22 | $372 | $17 |
| Lamotrigine | 31 | $149 | $5 |
2014: 1 drug
| Seroquel Xr | 14 | $10,909 | $779 |
Money from drug and device companies
$867 in 2025
| 2025 | 5 | 19 | None | $867 |
| 2024 | 6 | 15 | None | $578 |
| 2023 | 4 | 17 | None | $330 |
| 2022 | 7 | 26 | None | $801 |
| 2021 | 10 | 29 | None | $855 |
| 2020 | 6 | 20 | None | $546 |
| 2019 | 6 | 15 | None | $573 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Vanda Pharmaceuticals | Fanapt | $234 | 5 payments
|
| Axsome Therapeutics | Auvelity | $204 | 4 payments
|
| Otsuka America Pharmaceutical | Abilify Asimtufii | $201 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $157 | 2 payments
|
| Abbvie | Vraylar | $70 | 4 payments
|
See all 19 published payments
| Axsome Therapeutics | Meals · 2025-12-17 | Auvelity | $22 |
| Abbvie | Meals · 2025-12-05 | Vraylar | $16 |
| Vanda Pharmaceuticals | Meals · 2025-12-03 | Fanapt | $121 |
| Otsuka America Pharmaceutical | Meals · 2025-10-28 | Rexulti | $27 |
| Abbvie | Meals · 2025-10-14 | Vraylar | $18 |
| Vanda Pharmaceuticals | Meals · 2025-09-24 | Fanapt | $33 |
| Axsome Therapeutics | Meals · 2025-09-11 | Auvelity | $116 |
| Axsome Therapeutics | Meals · 2025-08-27 | Auvelity | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-08-18 | Rexulti | $22 |
| Abbvie | Meals · 2025-07-31 | Vraylar | $15 |
| Vanda Pharmaceuticals | Meals · 2025-06-18 | Fanapt | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-05-27 | Rexulti | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-03 | Cobenfy | $134 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-31 | Cobenfy | $23 |
| Axsome Therapeutics | Meals · 2025-03-26 | Auvelity | $35 |
| Vanda Pharmaceuticals | Meals · 2025-02-20 | Fanapt | $38 |
| Vanda Pharmaceuticals | Education · 2025-02-19 | Fanapt | $12 |
| Otsuka America Pharmaceutical | Meals · 2025-02-12 | Abilify Asimtufii | $125 |
| Abbvie | Meals · 2025-01-27 | Vraylar | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $578
| Axsome Therapeutics | Auvelity | $214 | 4 payments
|
| Abbvie | Vraylar | $155 | 6 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $129 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $40 | 2 payments
|
| Tris Pharma | Dyanavel Xr | $21 | 1 payment
|
| Corium | Azstarys | $19 | 1 payment
|
2023: $330
| Abbvie | Vraylar | $201 | 10 payments
|
| Alkermes | Aristada | $61 | 3 payments
|
| Tris Pharma | Dyanavel Xr | $55 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $14 | 1 payment
|
2022: $801
| Abbvie | Vraylar | $385 | 13 payments
|
| Alkermes | Lybalvi | $127 | 2 payments
|
| Sunovion Pharmaceuticals | Latuda | $85 | 3 payments
|
| Lundbeck | Rexulti | $78 | 3 payments
|
| Iti | Caplyta | $73 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $35 | 2 payments
|
| Teva Pharmaceuticals USA | Austedo | $18 | 1 payment
|
2021: $855
| Iti | Caplyta | $232 | 5 payments
|
| AbbVie | Vraylar | $230 | 10 payments
|
| Neurocrine Biosciences | Ingrezza | $111 | 1 payment
|
| Lundbeck | Brintellix | $85 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $85 | 4 payments
|
| Sunovion Pharmaceuticals | Latuda | $32 | 1 payment
|
| Bausch Health US | Aplenzin | $24 | 1 payment
|
| Eisai | Dayvigo | $22 | 1 payment
|
| Adlon Therapeutics L.P. | Adhansia Xr | $17 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $16 | 1 payment
|
2020: $546
| Allergan | Vraylar | $319 | 10 payments
|
| Iti | Caplyta | $125 | 5 payments
|
| Lundbeck | Rexulti | $42 | 2 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $25 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Vyvanse | $19 | 1 payment
|
| Bausch Health US | Aplenzin | $16 | 1 payment
|
2019: $573
| Allergan | Vraylar | $361 | 9 payments
|
| Otsuka America Pharmaceutical | Rexulti | $121 | 1 payment
|
| Shire North American Group | Vyvanse | $35 | 2 payments
|
| Ironshore Pharmaceuticals | Jornay Pm 20mg Capsules (Bottle of 100) | $24 | 1 payment
|
| Neurocrine Biosciences | Ingrezza | $16 | 1 payment
|
| Bausch Health US | Wellbutrin | $16 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Indivior Inc. · Quantitative Testing of Prescriber/Pharmacist Knowledge, Attitudes and Behavior About Suboxone (Buprenorphine and Naloxone) Sublingual Film (Ciii) Or the Authorized Generic of Suboxone Sublingual Film (Ciii) Safety and Use Information · 2020 | This clinician | $150 |
Professional record
- NPI
- 1760898100
- Licence
- CA G072595
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X); Federal specialty code 2084P0804X (2084P0804X)
- Mailing address
- 51 E. Campbell Ave. Ste. 170, Campbell, CA, 95008
- NPI first listed
- 2014-07-07
- NPI last updated
- 2014-07-07
This is when the NPI record was last certified, not a medical board exam.